Archives: 2026-04-29

Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no graft-versus-host-disease in leukemia patients

A phase 2 study published in the Journal of Clinical Oncology shows that a stem cell product called dilanubicel safely enabled umbilical cord blood transplants in 28 patients A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A

Read More


2026 American Heart Association Dietary Guidance to Improve Cardiovascular Health

Following 9 key steps for a lifetime of eating well can support heart health More than half of adults and about 60% of children in the U.S. have unhealthy diets, which can contribute to higher rates of health factors such as high blood pressure and obesity, and lead directly to poor health outcomes including deaths from cardiovascular disease and other

Read More


FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program

Groundbreaking AAV-based gene therapy offers potential treatment for patients with OTOF gene-associated severe-to-profound and profound hearing loss The U.S. Food and Drug Administration approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy. Otarmeni is indicated for the treatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss (any

Read More


CAR-T cells trials efficacy presented at the America Association for Cancer Research annual meeting

The third Clinical Trials Plenary Session at the AACR Annual Meeting 2026 was dedicated to “Cellular Therapies and Complex Immunotherapies” and provided updates on sophisticated immunotherapeutic CAR-T cells strategies, with special emphasis on their application for solid tumors.  Can CAR T-cell therapy intercept disease in patients with smoldering myeloma? The first presenter Omar Nadeem, MD, of

Read More


Redo Surgical Mitral Valve Replacement Shows Long-Term Survival Advantage Over Transcatheter Valve-in-Valve

 A new multicenter study published in The Annals of Thoracic Surgery finds that reoperative surgical mitral valve replacement (rSMVR) is associated with significantly better long-term survival compared to transcatheter mitral valve-in-valve (mViV) procedures in patients with failing bioprosthetic mitral valves. While both approaches demonstrated similar safety and procedural success at 30 days, key differences emerged over time,

Read More


Research published in JAMA: Mortality Among ICE Detainees Surging in 2026

Over a 22-year period, 272 deaths were reported; nearly half cited “undetermined” causes Key Takeaways Deaths among people detained by Immigration and Customs Enforcement (ICE) have increased in recent years after a long decline, and better monitoring of medical care and mortality rates in this population is needed, said researchers of a retrospective study. From

Read More